Pituitary adenoma (PA) accounts for approximately 15% in intracranial neoplasms. The classification of PA generally based on the hormone level of blood as the gold standard test, while the analysis of hormone condition using neuroimaging biomarkers was less explored. Accordingly, our study developed a model to automatically segment PA and further used the quantitative and non-invasive MRI technique as image biomarkers to classify the three types of hormone pattern, focusing on corticortroph, gonadotroph, and plurihormonal type. We aimed to provide a feasible classification model based MRI to benefit the clinical management of patients with PA.
No takes yet. Share an insight, caveat, or question.
Lin et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: